ADC Therapeutics SA is a clinical-stage biotechnology company, which engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
265
Frequently Asked Questions
What is Market Cap of Adc Therapeutics SA?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Adc Therapeutics SA market cap is $363.37M.
What is the 52-week high for Adc Therapeutics SA?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Adc Therapeutics SA 52 week high is $3.97 as of September 12, 2025.
What is the 52-week low for Adc Therapeutics SA?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Adc Therapeutics SA 52 week low is $1.05 as of September 12, 2025.
What is Adc Therapeutics SA stock price today?
Adc Therapeutics SA stock price today is $3.33.
What was Adc Therapeutics SA stock price yesterday?
Adc Therapeutics SA stock price yesterday was $3.23.
What is the PE ratio of Adc Therapeutics SA?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Adc Therapeutics SA’s P/E ratio is -2.06.
What is the Price-to-Book ratio of Adc Therapeutics SA?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Adc Therapeutics SA P/B ratio is -1.8243.
What is the 50-day moving average of Adc Therapeutics SA?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Adc Therapeutics SA 50-day moving average is $3.06.
